EP2040746A4 - Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins - Google Patents

Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins

Info

Publication number
EP2040746A4
EP2040746A4 EP07809720A EP07809720A EP2040746A4 EP 2040746 A4 EP2040746 A4 EP 2040746A4 EP 07809720 A EP07809720 A EP 07809720A EP 07809720 A EP07809720 A EP 07809720A EP 2040746 A4 EP2040746 A4 EP 2040746A4
Authority
EP
European Patent Office
Prior art keywords
env
trimers
proteins
processes
retroviral envelope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07809720A
Other languages
German (de)
French (fr)
Other versions
EP2040746A1 (en
Inventor
William C Olson
Paul J Maddon
Michael Franti
Sai Prasad N Iyer
Yun Kang
John P Moore
Simon Beddows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Progenics Pharmaceuticals Inc
Original Assignee
Cornell Research Foundation Inc
Progenics Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc, Progenics Pharmaceuticals Inc filed Critical Cornell Research Foundation Inc
Publication of EP2040746A1 publication Critical patent/EP2040746A1/en
Publication of EP2040746A4 publication Critical patent/EP2040746A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
EP07809720A 2006-06-19 2007-06-19 Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins Withdrawn EP2040746A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81511406P 2006-06-19 2006-06-19
PCT/US2007/014388 WO2007149490A1 (en) 2006-06-19 2007-06-19 Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins

Publications (2)

Publication Number Publication Date
EP2040746A1 EP2040746A1 (en) 2009-04-01
EP2040746A4 true EP2040746A4 (en) 2009-12-16

Family

ID=38833738

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07809720A Withdrawn EP2040746A4 (en) 2006-06-19 2007-06-19 Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins

Country Status (3)

Country Link
EP (1) EP2040746A4 (en)
CA (1) CA2655929A1 (en)
WO (1) WO2007149490A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011006205A (en) 2008-12-09 2011-09-01 Novavax Inc Modified rsv f proteins and methods of their use.
US11446374B2 (en) 2008-12-09 2022-09-20 Novavax, Inc. Modified RSV F proteins and methods of their use
US9738688B2 (en) 2012-11-05 2017-08-22 International Aids Vaccine Initiative HIV-1 envelope glycoprotein
WO2015171975A1 (en) * 2014-05-09 2015-11-12 The Regents Of The University Of Michigan Use of modified banana lectin in purification of glycoproteins
MX2018002728A (en) 2015-09-03 2018-09-05 Novavax Inc Vaccine compositions having improved stability and immunogenicity.
BR112020019108A2 (en) 2018-03-19 2020-12-29 Novavax, Inc. POLLVALENT NANOPARTICLE VACCINES OF INFLUENZA
CN114585639A (en) * 2019-11-07 2022-06-03 扬森疫苗与预防公司 Protein purification

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089526A1 (en) * 2001-09-06 2005-04-28 Moore John P. Human immunodeficiency virus envelope clycoprotein mutants and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781676B1 (en) * 1998-07-31 2004-04-02 Pasteur Merieux Serums Vacc QUARTER OF HIV ENV GENE EXPRESSION PRODUCT
EP2363143A3 (en) * 2003-03-28 2012-02-15 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services MVA expressing modified hiv envelope, gag, and pol genes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089526A1 (en) * 2001-09-06 2005-04-28 Moore John P. Human immunodeficiency virus envelope clycoprotein mutants and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SANDERS R W ET AL: "Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 76, no. 17, 1 September 2002 (2002-09-01), pages 8875 - 8889, XP002393505, ISSN: 0022-538X *
See also references of WO2007149490A1 *

Also Published As

Publication number Publication date
EP2040746A1 (en) 2009-04-01
WO2007149490A1 (en) 2007-12-27
CA2655929A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
EP2040746A4 (en) Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins
EP1984384A4 (en) Conotoxin analogues, and methods for synthesis of intramolecular dicarba bridge containing peptides
HK1112580A1 (en) Analogs of ghrelin (ghrelin)
HK1154636A1 (en) Preparation of templates for nucleic acid sequencing
DK1745136T3 (en) Process for enzymatic preparation of (S) -3-cyano-5-methylhexanoic acid
WO2006127899A3 (en) (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use
IL197014A0 (en) Process for the manufacture of snac (salcaprozate sodium)
EP1866074A4 (en) System for delivery of reagents from solid sources thereof
WO2006007207A3 (en) Methods and devices for nucleic acid sequence determination
IL214832A0 (en) 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
GB0524069D0 (en) Preparation of templates for solid phase amplification
PL1739093T3 (en) Separation of plasma proteins
EP1992698A4 (en) METHOD FOR SYNTHESIS OF SUPPRESSOR tRNA, DNA CONSTRUCT, AND PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN BY USING THE DNA CONSTRUCT
DK2041277T3 (en) PROCEDURE FOR THE PREPARATION OF SOLUBLE ARABINOXYLANES AS A BI PRODUCT FROM THE FERMENTATION OF COMPLETE GRAIN CHARACTERS
EP1887612A4 (en) Process for manufacture of bonded wafer
IL175517A0 (en) Processes for preparation of ziprasidone
IL194961A0 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
SI1713801T1 (en) Process for preparation of 1-(2s,3s)-2-benzhydr yl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
ITMI20072262A1 (en) PROCEDURE FOR THE PREPARATION OF ACID (S) (+) - 3- (AMINOMETHYL) -5-METHYLESANOIC
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
WO2009058800A3 (en) Synthesis of nucleosides
WO2007098273A3 (en) Novel crystalline forms of armodafinil and preparation thereof
ZA200900626B (en) 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
IL187855A0 (en) Processes for the preparation of docetaxel
EP1802332A4 (en) Modified hiv-1 envelope proteins

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BEDDOWS, SIMON

Inventor name: MOORE, JOHN P.

Inventor name: KANG, YUN

Inventor name: IYER, SAI PRASAD N.

Inventor name: FRANTI, MICHAEL

Inventor name: MADDON, PAUL J.

Inventor name: OLSON, WILLIAM C.

A4 Supplementary search report drawn up and despatched

Effective date: 20091118

17Q First examination report despatched

Effective date: 20100224

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100707